Description
Clinical Description
RRS® HA Cellutrix is a Class III injectable dermal implant developed by Skin Tech Pharma Group for the management of dermal surface irregularities associated with edematous fibrosclerotic panniculopathy, commonly referred to as cellulite. The formulation combines non-cross-linked hyaluronic acid with a protective biorevitalising buffer containing antioxidants, flavonoids, vitamins, saponins, amino acids, lipolytic compounds, and other supportive ingredients designed to assist tissue quality and skin appearance.
The product is intended for professional administration in areas affected by cellulite and skin laxity, including the thighs, buttocks, abdomen, arms, and legs. Hyaluronic acid contributes hydration and dermal support, while the accompanying protective complex is formulated to help maintain tissue homeostasis and support microcirculatory function.
RRS® HA Cellutrix is supplied in multidose vials and is intended exclusively for use by qualified healthcare professionals in authorised clinical settings.
What RRS® HA Cellutrix Is Similar To
RRS® HA Cellutrix belongs to the category of body mesotherapy and cellulite-management injectables. It is often compared with products such as RRS® Silisorg and other body-focused biorevitalisation formulations that combine hyaluronic acid with supportive active ingredients.
Compared with RRS® Silisorg, which focuses more heavily on connective tissue support through organic silicon-based ingredients, RRS® HA Cellutrix incorporates non-cross-linked hyaluronic acid together with a broad protective buffer containing antioxidants, flavonoids, vitamins, and lipolytic compounds.
It may also be compared with body mesotherapy cocktails used for cellulite and skin-quality improvement. Unlike volumising dermal fillers, these products are not designed to create structural volume but instead aim to improve the appearance of skin texture and tissue quality.
Results and treatment longevity vary according to individual patient factors, treatment area, and protocol selected by the practitioner.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer information and IFU documentation, RRS® HA Cellutrix is indicated for:
- Edematous fibrosclerotic panniculopathy (cellulite)
- Dermal surface irregularities associated with cellulite
- Improvement of skin quality in cellulite-affected areas
Treatment areas include:
- Thighs
- Buttocks
- Abdomen
- Arms
- Legs
Usage / Administration (IFU-Only)
Injection depth: Deep dermis (approximately 0.5–1 mm according to IFU documentation).
Volume per injection point: Not provided by manufacturer within official IFU dosage recommendations.
Needle gauge: 30G needle.
Frequency / number of sessions: Not provided by manufacturer in the publicly available IFU.
Professional-use statement: RRS® HA Cellutrix must be administered only by legally authorised medical professionals within authorised clinical settings and under appropriate aseptic conditions.
Technique: The IFU states that the physician may select the most appropriate injection technique, including serial puncture, linear retrograde, fan technique, or approved mesotherapy delivery systems.
Some practitioners apply structured cellulite-treatment protocols involving multiple sessions; these methods are not included in the manufacturer’s official IFU.
Ingredient List
Active Ingredients
- Sodium hyaluronate (non-cross-linked): 5 mg / 10 ml (0.5 mg/ml)
Protective Buffer Components
Includes:
- Antioxidants
- Flavonoids
- Vitamins
- Saponins
- Fucoxanthin
- Caffeine
- L-carnitine
- Polyphenols
- Trace elements
- Alpha-hydroxy acids (AHAs)
Presentation & Longevity
Packaging
- 6 × 10 ml sterile vials
- Total pack volume: 60 ml
Treatment duration / longevity: Not provided by manufacturer. Clinical outcomes may vary depending on treatment protocol, patient characteristics, lifestyle factors, and anatomical area treated.
Safety Notes / Contraindications
According to the manufacturer IFU, RRS® HA Cellutrix should not be used in:
- Patients with known hypersensitivity to any formulation component.
- Patients with active skin infection or inflammatory conditions at the treatment site.
- Patients with certain autoimmune disorders or severe systemic diseases where physician assessment determines treatment is unsuitable.
- Pregnant or breastfeeding patients, as adequate clinical studies have not been provided by the manufacturer.
Additional precautions:
- Do not inject into blood vessels, muscles, tendons, ligaments, bone, or internal organs.
- Patients receiving anticoagulant therapy may have an increased risk of bruising or haematoma formation.
Regulatory Status
- CE-marked Medical Device.
- Medical Device Class III according to manufacturer documentation.
- Intended for professional medical use only.
UKCA status: Verify via current IFU or authorised distributor documentation.
FAQ
1. What is RRS® HA Cellutrix used for?
RRS® HA Cellutrix is an injectable dermal implant developed for the treatment of cellulite-related skin irregularities and edematous fibrosclerotic panniculopathy. The formulation combines hyaluronic acid with a protective biorevitalising buffer to support skin quality and improve the appearance of affected body areas.
2. Does RRS® HA Cellutrix contain hyaluronic acid?
Yes. The formulation contains non-cross-linked sodium hyaluronate at a concentration of 5 mg per 10 ml vial (0.5 mg/ml). The hyaluronic acid is produced through biotechnological processes and is combined with a complex protective buffer containing antioxidants, flavonoids, vitamins, and other active compounds.
3. Which body areas can be treated with RRS® HA Cellutrix?
Manufacturer information identifies the thighs, buttocks, abdomen, arms, and legs as the principal treatment areas. These are regions commonly affected by cellulite-related skin texture changes and loss of smoothness.
4. Is RRS® HA Cellutrix a dermal filler?
No. Although it contains hyaluronic acid, RRS® HA Cellutrix is not designed as a volumising dermal filler. Instead, it functions as a biorevitalising injectable implant intended to improve skin quality and address cellulite-associated surface irregularities.
5. How does RRS® HA Cellutrix compare with other cellulite injectables?
RRS® HA Cellutrix combines hyaluronic acid with a broad spectrum of supportive ingredients including antioxidants, lipolytic compounds, flavonoids, vitamins, and amino acids. Compared with some alternative cellulite-focused mesotherapy products, it offers a comprehensive protective-buffer approach while remaining focused on skin quality and cellulite-related indications.
